Improvement of asymmetric thyroid eye disease with teprotumumab.
Shoaib UgradarYao WangTunde MesterGeorge J KahalyRaymond DouglasPublished in: The British journal of ophthalmology (2021)
The findings in this study suggest the differential impact of teprotumumab on orbits that are clinically more affected by TED, suggesting that teprotumumab reduces asymmetry.
Keyphrases